Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    thumbnail
    Making sense of the rapidly changing biosimilars landscape

    Strategies for adapting and achieving optimal market access

    thumbnail
    Building a comparative evidence base using network meta-analysis

    Methods, implementation and reporting

    banners
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    webinar
    When patients lead: Breaking barriers in ultra-rare disease drug development

    Watch the webinar.

    thumbnail
    ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change

    Watch the webinar.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. Solutions
  3. Laboratories
  4. Specialty Biomarker Laboratories
  5. Portland Specialty Lab

Portland Specialty Lab

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

ICON’s latest advancements at the Portland Specialty Lab have enhanced our ability to deliver flexible, cost-effective, and efficient solutions for sponsors requiring specialty laboratory testing.

Automated efficiencies

Custom workflows have historically included manual processes, such as the Qiagen column-based kits ( e.g., QIAamp Midi or Maxi kit) that can be more time-intensive, and prone to executional variability during more complex procedures. ICON’s investment in innovative tools and systems is part of a targeted automation strategy designed to support study-specific workflows to deliver sponsor results faster and more efficiently. 

Agile, fit for purpose technology

ICON’s most recent lab technology includes three different magnetic bead-based DNA-RNA extractors and a specialised liquid handler, all delivering unique capabilities. Magnetic bead DNA-RNA extraction has advanced in recent years and provides certain practical improvements over centrifuge-dependent methods. Magnetic bead methods require less space, are quicker, and provide high quality and lower cost extractions delivering significant amounts of extracted material. The speed at which these machines operate reduces manual input and enhances quality and efficiency.

Capitalising on the efficiencies of magnetic bead methods, ICON now offers sponsors a suite of options including: Promega Maxwell CSC, Revvity (Perkin-Elmer) Chemagic 360, and the ThermoFisher Kingfisher Flex DNA-RNA extractors. Utilising these instruments, ICON can accommodate a wide range of samples and batch sizes:

  • Batch sizes as small as 1 sample
  • Large batches up to 96 samples at a time
  • Small samples as low as 300 µL of blood or small quantities of PBMCs
  • Large samples up to 10 mL of blood 

Broader capabilities

The Hamilton MicroLab Prep liquid handler automates the liquid handling steps of many standard procedures; aiding in crucial steps like sample normalisation and reducing the risk of variability during manual pipetting. Automating liquid handling also supports more efficiency in: 

  • Pre-extraction workflows
  • Replicating plates
  • Performing serial dilutions
  • Blood sample aliquoting
  • Performing cherry-picking or hit-picking
  • Adding reagents
  • Incubating
  • PCR plate preparation

The liquid handler also provides sample tracking for a detailed, chronological audit trail supporting accountability and data integrity. 

Commitment to quality

ICON’s commitment to quality is core to the lab innovation strategy being implemented at our Portland facility. As ICON automates processes and platforms, we do so intentionally with a goal to improve our internal workflows and enhance the benefits we deliver to clients. The flexibility of options we have curated provides opportunities for accelerated timelines, right-sized custom workflows, and cost-effective services without compromising on quality. 

 

Contact us to learn how our specialty laboratory services can deliver real value to your clinical development programs. 

In this section
In this section
  • Consulting and advisory services
    • Externalised development
  • Asset Development Consulting
    • Adaptive trials
    • Dose optimisation strategies
    • Due diligence and asset valuation
    • Nonclinical and pre clinical development
    • Novel statistical methods
    • Protocol optimisation
    • Target product profile
  • Blended Solutions
  • Cardiac Safety Solutions
  • Clinical & Scientific Operations
    • Accelerated study start-up
    • Biostatistics and Programming
    • Clinical Operations
      • Clinical Monitoring
        • Risk based monitoring
      • Trial Master File services
    • Data Monitoring Committee Services
    • Clinical Supplies Management
    • COVID-19
      • COVID-19 treatment and vaccine trials
    • Clinical data science
      • CDISC Data Standardisation
    • Endpoint Adjudication Services
    • Global Logistics
      • Depot and Distribution Services
      • Global Logistics factsheets
    • Interactive Response Technology
      • Help Desk Services
    • Investigator Payments
      • Tax Management and Contracting
      • The Need for Flexibility
    • Medical Affairs
    • Medical Call Centre Services
    • Medical Writing
    • Pharmacovigilance
      • Post-marketing pharmacovigilance
      • Tailored pharmacovigilance solutions for biotech and small to mid-sized companies
      • Affiliate Level Solution
      • Ensuring patient safety
      • Risk Management & REMS Solutions
      • Safety Reporting Group
      • Safety writing solutions
    • Project and Program Management
  • Commercial Positioning
    • Health Economics and Outcomes Research
    • Market Access
    • Market Research & Analytics
    • Global Medical and Commercial Agency
    • Medical & Value Communications
      • Creative & Digital Services
        • Awards
      • Publication Management
    • Patient Reported Outcomes
  • Decentralised Clinical Trials
    • In-Home Services
  • Early Clinical
    • Accelerated Pharmaceutical Solutions
    • Bioanalytical Laboratories
    • Biometrics
    • Clinical Pharmacology
    • Clinical Research Facilities
    • Early Phase Oncology
    • Ethnic Bridging Studies
    • Medical Affairs
    • Early Phase Patient Studies
    • Early Phase Obesity Trials
    • Quality and Compliance
    • TQT studies
    • Quantitative Pharmacology and Pharmacometrics
    • Volunteer Recruitment
  • Language Services
    • Clinical and Medical Translations
    • Linguistic Validation
    • Translation Technologies
  • Laboratories
    • Bioanalytical Laboratories
      • Applications
        • Pharmacokinetics
        • Biomarkers
        • Immunogenicty
        • ADCs
        • ADME
        • Metabolites
        • Oligonucleotides
      • Technologies
        • Flow Cytometry
        • LC-MS/MS
        • Ligand Binding Assays
        • qPCR
        • Liquid Scintillation Counting (LSC)
    • Central Laboratories
      • Laboratory Client Services
        • Site Support Services
      • Study Management Tools
      • Digital Pathology
      • Global Data Services
      • Logistical Tools
      • Integrated Clinical Research & Laboratory Services
      • iRIS: A Focus on Local Laboratory Results
      • Laboratory Facilities
      • Quality Assurance
      • Testing Capabilities
    • Specialty Biomarker Laboratories
      • Laboratory Facilities
        • Cambridge Specialty Lab
        • Portland Specialty Lab
      • Biomarker testing portfolio
        • Genomics
        • Histopathology/IHC
        • Multiplex Immunofluorescence
        • Flow Cytometry
        • Biomarker test menu
    • Biospecimen Services
    • Biotech Laboratory Solutions
  • Medical Imaging
    • Collect and hold
    • Imaging therapeutic expertise
      • Metabolic disease
        • Obesity weight loss
        • MASH/MASLD
      • Cardiovascular
      • Central Nervous System
      • Oncology
    • Rescue studies
    • Technology platforms
  • Outcome Measures
    • Clinical Outcome Assessments
    • Digital Health Technologies
    • eCOA Technology
  • Real World Intelligence
    • Clinical Trial Tokenisation
    • Real World Evidence and Late Phase Research
      • Remote Monitoring for Late Phase
    • RWE Strategy and Analytics
  • Regulatory Affairs
    • Global Clinical Trials
    • Regulatory Project Services
    • Global Regulatory Strategy
    • CMC & Quality Services
    • Regulatory Operations
    • Global Labelling & Ad Promotion
    • Medical Device and Diagnostics
    • Clinical Diagnostics Regulatory Affairs: IVD/CDx
  • Symphony Health data
    • Symphony Health Conference Posters
    • Health technology and business intelligence solutions
      • Metys®
    • Integrated Dataverse and Source Solutions
    • Optimise brand strategy and sales effectiveness
      • HealthRankings
    • Solve market access challenges
    • Understand the patient journey
    • Making Medicines More Affordable
  • Site & Patient Solutions
    • Patient Centred Services
      • Concierge Services
      • Patient Insights and Engagement
      • Patient Recruitment
      • Accellacare site resourcing
      • Site engagement
    • Site & patient obesity solutions
    • Sites
      • ICON’s Elite Sites Program
      • Global Site Network
  • Strategic Solutions
    • Careers in Strategic Solutions
    • Data-enabled FSP
    • Organisational design
    • Technology-led innovation
  • Technologies
    • AI at ICON
      • One Search
      • Cassandra
      • EngageAI
    • LabView360
    • CARD
    • Signet
    • ARCADES
    • FIRECREST
      • SWIM
      • Site Portal
      • Learn
        • Training
        • Visit-by-Visit Guide
        • Medical Animation
        • Patient Education
      • Engage
        • Referral Management Console
        • Safety Letters
        • Site Question Management
        • Study News
        • Pre-Screen
        • Document Exchange and Tracking
    • ICON Digital Platform
    • OneView
    • ICON ORCA Safety
    • Evidence Platform
    • Control Tower
    • FLEX ADVANTAGE
    • Medical Imaging Technology
    • ICON ORCA Safety
    • NONMEM
      • NONMEM FAQs
    • Clinical Data Studio
    • PDx-POP
    • PubsHub
      • Journals & Congresses℠
      • Knowledge Manager℠
      • PMSolution℠
    • SIMS
    • ICOMaster for eTMF
    • Prism Connect
    • SmartDraft
    • HORIZON

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media
Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence